ECS Botanics Holdings Management
Management criteria checks 2/4
ECS Botanics Holdings' CEO is Nan-Maree Schoerie, appointed in Jun 2022, has a tenure of 2.5 years. total yearly compensation is A$520.84K, comprised of 60.9% salary and 39.1% bonuses, including company stock and options. directly owns 9.33% of the company’s shares, worth A$2.04M. The average tenure of the management team and the board of directors is 2.9 years and 0.1 years respectively.
Key information
Nan-Maree Schoerie
Chief executive officer
AU$520.8k
Total compensation
| CEO salary percentage | 60.9% |
| CEO tenure | 2.5yrs |
| CEO ownership | 9.3% |
| Management average tenure | 2.9yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop
Nov 11
There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise
Sep 27ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business
Aug 12There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding
Apr 03ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk
Sep 06ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans
Feb 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$521k | AU$317k | AU$2m |
| Mar 31 2024 | n/a | n/a | AU$2m |
| Dec 31 2023 | n/a | n/a | AU$2m |
| Sep 30 2023 | n/a | n/a | AU$1m |
| Jun 30 2023 | AU$323k | AU$227k | AU$491k |
| Dec 31 2022 | n/a | n/a | AU$2m |
| Sep 30 2022 | n/a | n/a | AU$1m |
| Jun 30 2022 | AU$188k | AU$178k | AU$166k |
| Mar 31 2022 | n/a | n/a | -AU$3m |
| Dec 31 2021 | n/a | n/a | -AU$4m |
| Sep 30 2021 | n/a | n/a | -AU$4m |
| Jun 30 2021 | AU$162k | AU$47k | -AU$4m |
Compensation vs Market: Nan-Maree's total compensation ($USD323.76K) is about average for companies of similar size in the Australian market ($USD286.38K).
Compensation vs Earnings: Nan-Maree's compensation has increased by more than 20% in the past year.
CEO
Nan-Maree Schoerie
2.5yrs
Tenure
AU$520,836
Compensation
Ms. Nan-Maree Schoerie, Dip Chem has been Executive Director at ECS Botanics Holdings Ltd since March 15, 2021 and also its Managing Director from June 14, 2022. She is Executive General Manager of medicin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 2.5yrs | AU$520.84k | 9.33% A$ 2.0m | |
| Chief Financial Officer | no data | AU$262.26k | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Head of European Operations | 3.3yrs | no data | no data | |
| Company Secretary | 7.1yrs | no data | no data |
2.9yrs
Average Tenure
Experienced Management: ECS's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 3.8yrs | AU$520.84k | 9.33% A$ 2.0m | |
| Non-Executive Chairman | 7.9yrs | AU$86.55k | 0.47% A$ 103.7k | |
| Non-Executive Director | 5.8yrs | AU$39.96k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data | |
| Member of Medical Advisory Board | less than a year | no data | no data |
0.08yrs
Average Tenure
Experienced Board: ECS's board of directors are not considered experienced ( 0.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 08:51 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ECS Botanics Holdings Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stuart Roberts | Pitt Street Research Pty Ltd. |